Related Experiment Videos
Computerized interactive morphometry. An expert system for the diagnosis of lymphoid-rich effusions
1Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California 90048.
American Journal of Clinical Pathology
|December 1, 1989
Summary
Computerized interactive morphometry (CIM) aids in diagnosing lymphoid effusions. While effective for most cases, CIM showed limitations in diagnosing chronic lymphocytic leukemia (CLL).
Area of Science:
- Cytopathology
- Medical Informatics
- Hematology
Background:
- Distinguishing malignant lymphoma from benign lymphocytosis in effusions is clinically significant.
- Traditional methods can be labor-intensive and require specialized expertise.
- Computerized analysis offers potential for objective and efficient diagnostic support.
Purpose of the Study:
- To evaluate the efficacy of a microcomputer-based video system for computerized interactive morphometry (CIM) in diagnosing lymphoid-rich effusions.
- To assess CIM's accuracy in differentiating malignant lymphoma from benign lymphocytosis.
- To determine CIM's suitability for diagnosing chronic lymphocytic leukemia (CLL) in effusions.
Main Methods:
- A Papanicolaou-fixed and stained cytospin smear system was developed for lymphoid cell analysis.
- Lymphoid cells were selected from real-time images of pleural, peritoneal, or pericardial effusions.
- An expert system classified cells based on nuclear profile size and shape, differentiating benign from malignant.
Main Results:
- The CIM system correctly classified 91 out of 104 effusions (87.5%).
- Excluding chronic lymphocytic leukemia (CLL) cases, CIM achieved 96.5% predictive value for malignant lymphoma and 94.0% for benign lymphocytosis.
- CIM consistently misclassified eight CLL effusions as benign, indicating unsuitability for this specific diagnosis.
Conclusions:
- Computerized interactive morphometry (CIM) shows promise for diagnosing lymphoid effusions, with high accuracy in differentiating malignant lymphoma from benign lymphocytosis.
- CIM is not suitable for diagnosing malignancy in effusions from patients with chronic lymphocytic leukemia (CLL).
- Further refinement of CIM may be needed for specific hematologic conditions like CLL.